In contrast, while ALT levels were higher in patients with NAFLD during the febrile phase, there were no significant differences in other laboratory markers of disease severity between the no leakage-NAFLD and no leakage+NAFLD groups. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.